| Literature DB >> 17651120 |
Yoshio Ootaki1, Chiyo Ootaki, Keiji Kamohara, Masatoshi Akiyama, Faruk Cingoz, Michael W Kopcak, Raymond Dessoffy, Jenny Liu, Alex Massiello, David Horvath, Ji-Feng Chen, Qun Zhou, Stephen Benefit, Leonard A R Golding, Kiyotaka Fukamachi.
Abstract
The DexAide right ventricular assist device (RVAD) has been developed to provide an implantable RVAD option to surgeons. The aim of this study was to determine the optimal cannula design and optimal implantation location of the DexAide RVAD in preparation for its clinical use. Separately, a HeartMate XVE left ventricular assist device (LVAD) and CorAide LVAD models were implanted into the preperitoneal and right thoracic space, and the anatomical fit of the DexAide RVAD was evaluated in five preserved human cadavers. The DexAide RVAD inflow cannula was inserted through the diaphragmatic surface of the right ventricle and the outflow was directed to the pulmonary artery. Right thoracic implantation of the DexAide RVAD provided an excellent fit with either the HeartMate or CorAide LVAD in all cadavers. The results of this study will guide improvements in the designs of cannulae and implantation of the DexAide RVAD in future clinical applications.Entities:
Mesh：
Year: 2007 PMID： 17651120 DOI： 10.1111/j.1525-1594.2007.00438.x
Source DB: PubMed Journal: Artif Organs ISSN： 0160-564X Impact factor: 3.094